1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9979):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W759947
    24-Nor ursodeoxycholic acid-d5 acyl-b-D-glucuronide
    24-Nor ursodeoxycholic acid-d5 acyl-b-D-glucuronide is the deuterium labeled 24-Nor ursodeoxycholic acid-d5 acyl-b-D-glucuronide (HY-W759947).
    24-Nor ursodeoxycholic acid-d5 acyl-b-D-glucuronide
  • HY-79128S1
    Fmoc-L-Lys (Boc)-OH-13C6,15N2
    99.90%
    Fmoc-L-Lys (Boc)-OH-13C6,15N2 is a 15N-labeled and 13C-labled Fmoc-L-Lys (Boc)-OH (HY-79128). Fmoc-L-Lys (Boc)-OH is a lysine derivative.
    Fmoc-L-Lys (Boc)-OH-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>2</sub>
  • HY-W688436S
    1,1-Diethoxyheptane-d10
    1,1-Diethoxyheptane-d10 is a deuterated labeled 1,1-Diethoxyheptane.
    1,1-Diethoxyheptane-d<sub>10</sub>
  • HY-165675S
    (Z)-10-Oxooctadec-12-enoic-17,17,18,18,18-d5 acid
    (Z)-10-Oxooctadec-12-enoic-17,17,18,18,18-d5 acid is deuterium labeled (Z)-10-Oxooctadec-12-enoic-17,17,18,18,18 acid.
    (Z)-10-Oxooctadec-12-enoic-17,17,18,18,18-d<sub>5</sub> acid
  • HY-17410S2
    Iloperidone-13C,d3
    Iloperidone-13C,d3 (HP 873-13C,d3) is 13C labeled Iloperidone. Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms.
    Iloperidone-<sup>13</sup>C<sub>,d<sub>3</sub>
  • HY-15440AS
    Fostemsavir-d8
    Fostemsavir-d8 (BMS-663068-d8) is deuterium labeled Fostemsavir. Fostemsavir (BMS-663068) is the phosphonooxymethyl prodrug of BMS-626529. Fostemsavir (BMS-663068) is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.
    Fostemsavir-d<sub>8</sub>
  • HY-Y0134S
    Fmoc-Glu(OtBu)-OH-15N
    Fmoc-Glu(OtBu)-OH-15N is a 15N-labeled Fmoc-Glu(OtBu)-OH.
    Fmoc-Glu(OtBu)-OH-<sup>15</sup>N
  • HY-B1204S1
    Histamine-d4
    Histamine-d4 (Ergamine-d4) is deuterium labeled Histamine (HY-B1204). Histamine is the agonist for histamine receptor and a vasodilator. Histamine is an organic nitrogen compound that participates in local immune responses, regulates intestinal physiological functions, and acts as a neurotransmitter. Histamine affects p38 MAPK/Akt signaling pathway, exhibits antitumor, antioxidant and anti-inflammatory activities. Histamine can be used in the research of acute myeloid leukemia, malignant melanoma, and renal cell carcinoma.
    Histamine-d<sub>4</sub>
  • HY-42397S
    1-Bromo-2-fluorobenzene-d4
    99.0%
    1-Bromo-2-fluorobenzene-d4 is the deuterium labeled 1-Bromo-2-fluorobenzene.
    1-Bromo-2-fluorobenzene-d<sub>4</sub>
  • HY-B0103AS2
    Fluvoxamine-13C, d3 maleate
    Fluvoxamine-13C, d3 maleate is 13C and deuterated labeled Fluvoxamine maleate (HY-B0103A). Fluvoxamine maleate (DU-23000 maleate) is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.
    Fluvoxamine-<sup>13</sup>C, d<sub>3</sub> maleate
  • HY-A0181S6
    Adenosine monophosphate-13C10,15N5
    Adenosine monophosphate-13C10,15N5 (AMP-13C10,15N5) is the 13C- and 15N-labeled Adenosine monophosphate (HY-A0181). Adenosine monophosphate is an adenosine A1 receptor agonist. Adenosine monophosphate has significant antiviral activity against HSV-1 and HSV-2. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.
    Adenosine monophosphate-<sup>13</sup>C<sub>10</sub>,<sup>15</sup>N<sub>5</sub>
  • HY-10466S1
    Daclatasvir-13C2,d6
    Daclatasvir-13C2,d6 (BMS-790052-13C2,d6) is 13C and deuterium labeled Daclatasvir. Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively.
    Daclatasvir-<sup>13</sup>C<sub>2</sub>,d<sub>6</sub>
  • HY-B0377S1
    Famotidine-13C
    Famotidine-13C (MK-208-13C) is 13C labeled Famotidine. Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
    Famotidine-<sup>13</sup>C
  • HY-W748350
    2,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenyl-13C12
    2,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenyl-13C12 is 13C labeled 2,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenyl.
    2,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenyl-<sup>13</sup>C<sub>12</sub>
  • HY-66011BS
    (Rac)-Moxifloxacin-d4
    (Rac)-Moxifloxacin-d4 ((Rac)-BAY 12-8039-d4 (free base)) is deuterium labeled (Rac)-Moxifloxacin. (Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is the isoform of Moxifloxacin Hydrochloride (HY-66011), which is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
    (Rac)-Moxifloxacin-d<sub>4</sub>
  • HY-B0089S
    Acarbose-d4
    Acarbose-d4 (BAY g 5421-d4) is deuterium labeled Acarbose. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin.
    Acarbose-d<sub>4</sub>
  • HY-W024104S
    2-(4-Fluorophenyl)pyridine-d8
    2-(4-Fluorophenyl)pyridine-d8 is the deuterium labeled 2-(4-Fluorophenyl)pyridine (HY-W024104).
    2-(4-Fluorophenyl)pyridine-d<sub>8</sub>
  • HY-W653875
    Azithromycin-d5
    Azithromycin-d5 (CP-62993-d5) is the deuterium labeled Azithromycin (CP-62993) (HY-17506). Azithromycin is a macrolide antibiotic useful for thestudy of a number of bacterial infections.
    Azithromycin-d<sub>5</sub>
  • HY-128417S4
    alpha-D-glucose13C6
    alpha-D-glucose-13C6 is 13C-labeled alpha-D-glucose (HY-128417). alpha-D-glucose is an endogenous metabolite.
    alpha-D-glucose<sup>13</sup>C<sub>6</sub>
  • HY-W145492S3
    D-(+)-Talose-13C-1
    99.0%
    D-(+)-Talose-13C-1 is the 13C labeled D-(+)-Talose.
    D-(+)-Talose-<sup>13</sup>C-1